| Followers | 17 |
| Posts | 5019 |
| Boards Moderated | 0 |
| Alias Born | 04/13/2016 |
Monday, September 05, 2016 8:16:26 AM
Options for moving KBLB forward: Dilution or ???
Truth, Bananarama, as far as I can tell, every option KBLB has to fund operations until the point of significant sales involves dilution in one form or another.
1) KBLB does not have enough obvious assets to apply for a loan of any size. Although we all realize the potential value of the company, he doesn't even have a patent awarded that he could use to make a loan against.
2) A joint venture is also a kind of dilution, with one side putting up some money (and expecting something in return) while KBLB puts up its GMO silkworms.
3) A venture capitalist would insist on something valuable for his/her investment, such as shares of preferred stock. (Boy would that make my stock worthless quickly!)
4) Selling more shares to Calm Seas obviously dilutes the value of shares.
5) KBLB is not well positioned to apply for government grants. Grants preferentially go to non-profit organizations like Universities. They preferentially are awarded to Ph.D. applicants. They come with some very heavy restrictions on administration that KBLB would not qualify for with its current staffing.
What possibility or possibilities am I missing? It seems to me the only way to move forward is to continue dilution in one form or another until the checks start coming in. The $1 million from the Army will be a good snack, but KBLB is burning through money pretty fast these days...
Truth, Bananarama, as far as I can tell, every option KBLB has to fund operations until the point of significant sales involves dilution in one form or another.
1) KBLB does not have enough obvious assets to apply for a loan of any size. Although we all realize the potential value of the company, he doesn't even have a patent awarded that he could use to make a loan against.
2) A joint venture is also a kind of dilution, with one side putting up some money (and expecting something in return) while KBLB puts up its GMO silkworms.
3) A venture capitalist would insist on something valuable for his/her investment, such as shares of preferred stock. (Boy would that make my stock worthless quickly!)
4) Selling more shares to Calm Seas obviously dilutes the value of shares.
5) KBLB is not well positioned to apply for government grants. Grants preferentially go to non-profit organizations like Universities. They preferentially are awarded to Ph.D. applicants. They come with some very heavy restrictions on administration that KBLB would not qualify for with its current staffing.
What possibility or possibilities am I missing? It seems to me the only way to move forward is to continue dilution in one form or another until the checks start coming in. The $1 million from the Army will be a good snack, but KBLB is burning through money pretty fast these days...
Recent KBLB News
- Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations • GlobeNewswire Inc. • 05/26/2026 11:35:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:19 PM
- Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform • GlobeNewswire Inc. • 05/20/2026 11:35:00 AM
- Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB) • IH Market News • 05/18/2026 03:12:33 PM
- Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications • GlobeNewswire Inc. • 05/18/2026 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2026 12:14:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:05 AM
- The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer • GlobeNewswire Inc. • 05/13/2026 01:05:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/11/2026 08:30:47 PM
- Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up • GlobeNewswire Inc. • 05/11/2026 11:05:00 AM
- Kraig Biocraft Laboratories Positions Itself as a Front-Runner in Spider Silk Race • GlobeNewswire Inc. • 05/07/2026 01:05:00 PM
- Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output • GlobeNewswire Inc. • 05/04/2026 11:05:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 09:07:15 PM
- Kraig Biocraft (KBLB) Spider Silk Production Milestone Signals Progress Toward Commercialization • IH Market News • 04/30/2026 02:54:26 PM
- Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations • GlobeNewswire Inc. • 04/30/2026 01:20:00 PM
- Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone — Spider Silk Push Moves Closer to Commercial Scale • IH Market News • 04/28/2026 01:51:39 PM
- Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk • GlobeNewswire Inc. • 04/28/2026 11:05:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
